These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9766781)

  • 21. Factors contributing to failed trials of new agents: can technology prevent some problems?
    Greist JH; Mundt JC; Kobak K
    J Clin Psychiatry; 2002; 63 Suppl 2():8-13. PubMed ID: 15453008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman M; Mattia JI; Posternak MA
    Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of a Guideline on Clinical investigation of Medicinal Product in the Treatment of Depression in Japan].
    Nakabayashi T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):169-76. PubMed ID: 21941851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward rapproachment in the placebo control debate. A calculated compromise of power.
    Leon AC; Solomon DA
    Eval Health Prof; 2003 Dec; 26(4):404-14. PubMed ID: 14631611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The case for practical clinical trials in psychiatry.
    March JS; Silva SG; Compton S; Shapiro M; Califf R; Krishnan R
    Am J Psychiatry; 2005 May; 162(5):836-46. PubMed ID: 15863782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signal detection and placebo response in schizophrenia: parallels with depression.
    Mallinckrodt CH; Zhang L; Prucka WR; Millen BA
    Psychopharmacol Bull; 2010; 43(1):53-72. PubMed ID: 20581800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis.
    Kim SY; Holloway RG
    Am J Psychiatry; 2003 Jul; 160(7):1272-6. PubMed ID: 12832241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the three-arm non-inferiority trial including a placebo with a prespecified margin.
    Hida E; Tango T
    Stat Med; 2011 Feb; 30(3):224-31. PubMed ID: 21213340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of methodological issues of clinical trials in multiple sclerosis.
    Montalban X
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial.
    Zimmerman M; Chelminski I; Posternak MA
    Am J Psychiatry; 2005 Jul; 162(7):1370-2. PubMed ID: 15994721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.
    Sinyor M; Levitt AJ; Cheung AH; Schaffer A; Kiss A; Dowlati Y; Lanctôt KL
    J Clin Psychiatry; 2010 Mar; 71(3):270-9. PubMed ID: 20122371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract]   [Full Text] [Related]  

  • 35. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A; Goldsmith C
    Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract]   [Full Text] [Related]  

  • 36. Conducting an antidepressant clinical trial in oncology: challenges and strategies to address them.
    Park EM; Raddin RS; Nelson KM; Hamer RM; Mayer DK; Bernard SA; Rosenstein DL
    Gen Hosp Psychiatry; 2014; 36(5):474-6. PubMed ID: 24939645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.
    Dawson R; Lavori PW
    Stat Med; 2004 Nov; 23(21):3249-62. PubMed ID: 15490427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A two-period crossover design for the comparison of two active treatments and placebo.
    Koch GG; Amara IA; Brown BW; Colton T; Gillings DB
    Stat Med; 1989 Apr; 8(4):487-504. PubMed ID: 2657956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sample sizes in the multivariate analysis of repeated measurements.
    Vonesh EF; Schork MA
    Biometrics; 1986 Sep; 42(3):601-10. PubMed ID: 3567293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.